Cargando…
ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma
INTRODUCTION: ARTEMIN (ARTN) is an estrogen regulated growth factor, the expression of which promotes resistance to antiestrogen therapies and predicts poorer survival outcome of patients with estrogen receptor (ER) positive mammary carcinoma (ER+MC) treated with tamoxifen. ARTN is also expressed in...
Autores principales: | Banerjee, Arindam, Wu, Zheng-Sheng, Qian, PengXu, Kang, Jian, Pandey, Vijay, Liu, Dong-Xu, Zhu, Tao, Lobie, Peter E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326554/ https://www.ncbi.nlm.nih.gov/pubmed/22060274 http://dx.doi.org/10.1186/bcr3054 |
Ejemplares similares
-
ARTEMIN Promotes De Novo Angiogenesis in ER Negative Mammary Carcinoma through Activation of TWIST1-VEGF-A Signalling
por: Banerjee, Arindam, et al.
Publicado: (2012) -
Prognostic significance of the expression of GFRα1, GFRα3 and Syndecan-3, proteins binding ARTEMIN, in mammary carcinoma
por: Wu, Zheng-Sheng, et al.
Publicado: (2013) -
ARTEMIN Promotes Oncogenicity and Resistance to 5-Fluorouracil in Colorectal Carcinoma by p44/42 MAPK Dependent Expression of CDH2
por: Zhuang, Qiu-Shi, et al.
Publicado: (2021) -
Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma
por: Zhang, Min, et al.
Publicado: (2015) -
Artemin and an Artemin-Derived Peptide, Artefin, Induce Neuronal Survival, and Differentiation Through Ret and NCAM
por: Ilieva, Mirolyuba, et al.
Publicado: (2019)